Other highlights in the July 19 JNCI

DNA In Urine May Detect Bladder Cancer

Bladder cancer can be detected using a test that examines nine genes from DNA found in a patient's urine, a study reports.

David Sidransky, M.D., of the Johns Hopkins School of Medicine in Baltimore, Md., and colleagues tested the tumor DNA and the urine DNA of 15 patients with bladder cancer and 25 controls to identify biomarkers for this cancer. They then used these markers to see if they could detect bladder cancer in 160 patients and 69 controls.

The authors found that the genetic patterns in urine DNA matched those in tumor DNA. In this way, they were able to use DNA samples from urine as a noninvasive method to identify genetic markers for patients with bladder cancer.

They write that larger, long-term follow-up "will be required in future studies to define the impact of this technology on early detection, prognosis, and disease monitoring before clinical application."

Contact: Valerie Mehl, mehlva@jhmi.edu

High Pesticide Exposure Raises Risk of Liver Cancer

DDT exposure may increase a person's chance of developing liver cancer, a study shows.

Katherine A. McGlynn, Ph.D., of the National Cancer Institute in Rockville, Md., and colleagues identified 168 patients with liver cancer and 385 controls among participants in the Nutritional Intervention Trials in Linxian, China. They measured the subjects' pre-diagnostic serum levels of DDT and of product the DDT breaks down into, called DDE.

High levels of DDT in blood serum plasma were associated with an increased risk of developing liver cancer, particularly among individuals with low DDE levels. The authors suggest that direct DDT exposure may increase a person's risk of developing liver cancer or that some individuals may be more susceptible to the effects of DDT because of a decreased ability to break down DDT into

Contact: Ariel Whitworth
Journal of the National Cancer Institute

Page: 1 2 3

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights from the July 10 JNCI
4. Other highlights in JNCI, June 26
5. Other highlights in JNCI, June 12
6. Other highlights from the June 6 JNCI
7. Other highlights in the May 16 JNCI
8. Other highlights from the April 18 Journal of the National Cancer Institute
9. Other highlights from the March 21 JNCI
10. Other highlights in the March 7 JNCI
11. Other highlights in the Feb. 21 JNCI

Post Your Comments:

(Date:6/4/2019)... ... ... Harper was three years old when her owners took her to the veterinarian ... in the joints. She was referred to a veterinary specialist to perform “salvage ... Christopher Eich of Southern California Veterinary Specialty Hospital , examined Harper and recommended ...
(Date:5/31/2019)... ... May 29, 2019 , ... ... Windows and mobile, announces the launch of version 13.1. The new version extends ... Management API, and supports Apple’s spring release functionality. Version 13.1 builds on FileWave’s ...
(Date:5/26/2019)... (PRWEB) , ... May 24, 2019 , ... Zolgensma (Novartis, ... as AVXS-101, was approved for clinical use in the United States by the Food ... virally-delivered gene therapy approved to treat inherited genetic disorders in the United States and ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... , ... June 11, 2019 , ... ... Personalized Stem Cells Inc. (PSC) , has announced that their GMP facility ... Food and Drug Branch for manufacturing. This is an important milestone for ...
(Date:6/6/2019)... ... 05, 2019 , ... WCCT Global, Inc ., a full-service early phase ... they will be receiving 3 awards at the 2019 CRO Leadership Awards, to be ... the categories of overall Quality and Compatibility (Access to desired markets, cultural fit, timely ...
(Date:5/31/2019)... Redwood City, California (PRWEB) , ... ... ... received allowance of our patent applications from the USPTO providing proprietary interest ... SYSTEM AND METHOD FOR SLEEP DISORDER DIAGNOSIS AND TREATMENT… extends Somnology’s IP ...
(Date:5/31/2019)... ... May 30, 2019 , ... Object ... announce the strategic acquisition of Metabiologics, Inc., a globally recognized leader in the ... ownership and commercialization rights to a full spectrum of botulinum neurotoxins, as well ...
Breaking Biology Technology:
Cached News: